Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
31,523,534
-
Total 13F shares
-
1,432,450
-
Share change
-
-176,550
-
Total reported value
-
$4,292,408
-
Put/Call ratio
-
7.1%
-
Price per share
-
$2.96
-
Number of holders
-
15
-
Value change
-
-$520,632
-
Number of buys
-
3
-
Number of sells
-
7
Institutional Holders of ImmunoPrecise Antibodies Ltd. - Common Shares, no par value (IPA) as of Q2 2023
As of 30 Jun 2023 ImmunoPrecise Antibodies Ltd. - Common Shares, no par value (IPA) had 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,432,450 shares of stock of the company.
Largest 10 holders included INGALLS & SNYDER LLC, BANK OF MONTREAL /CAN/, Federation des caisses Desjardins du Quebec, CIBC WORLD MARKET INC., CITADEL ADVISORS LLC, Gradient Capital Advisors, LLC, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), and Royal Bank of Canada.
This table shows 15 institutional shareholders of the security as of 30 Jun 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.